Sunwin management to discuss growth strategies at the 2009 Rodman & Renshaw Annual Global Investment Conference

Sunwin International Neutraceuticals, Inc. (OTCBB: SUWN), a leader in the production and distribution of Chinese herbs, veterinary medicines and one of the world's leading producers of all natural, zero calorie stevia in China, will present at the Rodman & Renshaw Annual Global Investment Conference taking place at the New York Palace Hotel September 9-11 as part of the Asia Track program on September 10th at 8:45 AM. Management of Sunwin will provide an overview of the company's business, as well as discuss management's growth strategies and plans for the remainder of 2009 and beyond.

The company will also host additional one-on-one investor meetings in New York from September 7, 2009 until September 11, 2009. To attend the Rodman conference or schedule a meeting at the conference, please contact the conference organizer. Individual meetings hosted by management of Sunwin in New York or teleconferences with institutional investors can be arranged by contacting Andrew Barwicki on behalf of the company at 516-662-9461.

Sunwin's Chief Executive Officer, Dongdong Lin, commented, "We are excited to be invited to the Rodman conference and look forward to presenting the exciting future of our company. Despite the global economic downturn, we have sustained our profitability and positioned the company for future growth. We intend to look to participate in additional conferences and meetings throughout the fall in order to increase the company's exposure to the investment community."

Source:

Sunwin International Neutraceuticals, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Drug-resistant SARS-CoV-2 variants found in immunocompromised patients